Literature DB >> 2878364

A single amino acid substitution in v-erbB confers a thermolabile phenotype to ts167 avian erythroblastosis virus-transformed erythroid cells.

O R Choi, C Trainor, T Graf, H Beug, J D Engel.   

Abstract

A library of recombinant bacteriophage was prepared from ts167 avian erythroblastosis virus-transformed erythroid precursor cells (HD6), and integrated proviruses from three distinct genomic loci were isolated. A subclone of one of these proviruses (pAEV1) was shown to confer temperature-sensitive release from transformation of erythroid precursor cells in vitro. The predicted amino acid sequence of the v-erbB polypeptide from the mutant had a single amino acid change when compared with the wild-type parental virus. When the wild-type amino acid was introduced into the temperature-sensitive avian erythroblastosis virus provirus in pAEV1, all erythroid clones produced in vitro were phenotypically wild type. The mutation is a change from a histidine to an aspartic acid in the temperature-sensitive v-erbB polypeptide. It is located in the center of the tyrosine-specific protein kinase domain and corresponds to amino acid position 826 of the human epidermal growth factor receptor sequence.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878364      PMCID: PMC367703          DOI: 10.1128/mcb.6.5.1751-1759.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Erythroblast cell lines transformed by a temperature-sensitive mutant of avian erythroblastosis virus: a model system to study erythroid differentiation in vitro.

Authors:  H Beug; G Doederlein; C Freudenstein; T Graf
Journal:  J Cell Physiol Suppl       Date:  1982

2.  Virus-specific RNAs in cells infected by avian myelocytomatosis virus and avian erythroblastosis virus: modes of oncogene expression.

Authors:  D Sheiness; B Vennstrom; J M Bishop
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

3.  Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses.

Authors:  T Graf; A von Kirchbach; H Beug
Journal:  Exp Cell Res       Date:  1981-02       Impact factor: 3.905

Review 4.  Avian leukemia viruses. Oncogenes and genome structure.

Authors:  T Graf; D Stéhelin
Journal:  Biochim Biophys Acta       Date:  1982-06-28

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus.

Authors:  H Beug; S Palmieri; C Freudenstein; H Zentgraf; T Graf
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

7.  Avian erythroblastosis virus produces two mRNA's.

Authors:  S M Anderson; W S Hayward; B G Neel; H Hanafusa
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

8.  Trans-complementable copy-number mutants of plasmid ColE1.

Authors:  A J Twigg; D Sherratt
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

9.  Nucleotide sequence of the E coli gene coding for dihydrofolate reductase.

Authors:  D R Smith; J M Calvo
Journal:  Nucleic Acids Res       Date:  1980-05-24       Impact factor: 16.971

10.  Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus.

Authors:  B Vennström; J M Bishop
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

View more
  20 in total

1.  Dissecting the activating mutations in v-erbB of avian erythroblastosis virus strain R.

Authors:  H K Shu; R J Pelley; H J Kung
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.

Authors:  S Massoglia; A Gray; T J Dull; S Munemitsu; H J Kun; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

3.  Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB.

Authors:  A Wells; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Disease tropism of c-erbB: effects of carboxyl-terminal tyrosine and internal mutations on tissue-specific transformation.

Authors:  R J Pelley; N J Maihle; C Boerkoel; H K Shu; T H Carter; C Moscovici; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Proviral insertional activation of c-erbB: differential processing of the protein products arising from two alternate transcripts.

Authors:  N J Maihle; M A Raines; T W Flickinger; H J Kung
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

6.  Mechanism of c-erbB transduction: newly released transducing viruses retain poly(A) tracts of erbB transcripts and encode C-terminally intact erbB proteins.

Authors:  M A Raines; N J Maihle; C Moscovici; L Crittenden; H J Kung
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

7.  The DNA-binding properties of two heat shock factors, HSF1 and HSF3, are induced in the avian erythroblast cell line HD6.

Authors:  A Nakai; Y Kawazoe; M Tanabe; K Nagata; R I Morimoto
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Tissue- and transformation-specific phosphotyrosyl proteins in v-erbB-transformed cells.

Authors:  M J McManus; D C Connolly; N J Maihle
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection.

Authors:  J E Strong; P W Lee
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Modulation of erbB kinase activity and oncogenic potential by single point mutations in the glycine loop of the catalytic domain.

Authors:  H K Shu; C M Chang; L Ravi; L Ling; C M Castellano; E Walter; R J Pelley; H J Kung
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.